Horizons Chronic Graft-Versus-Host-Disease Study
Conditions: Graft Vs Host Disease; Coping Skills; Quality of Life; Stem Cell Transplant Complications Interventions: Behavioral: Horizons Group Intervention Sponsors: University of Miami Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Stem Cell Study for Long COVID-19 Neurological Symptoms
Conditions: Post-Acute COVID-19 Syndrome Interventions: Biological: Stem Cell Sponsors: Charles Cox; CBR Systems, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
Conditions: Leukemia; Stem Cell Transplant; Cord Blood Interventions: Procedure: applying of FLU+CY post-HSCT Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support
Conditions: Heart Failure; Mechanical Circulatory Support Interventions: Biological: CD34+ stem cell therapy Sponsors: University Medical Centre Ljubljana Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
Conditions: Mesenchymal Stem Cells Interventions: Biological: Mesenchymal Stem Cells (MSCs) Sponsors: Southwest Hospital, China; Xinqiao Hospital of Chongqing Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Conditions: Hematologic Diseases; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation Interventions: Device: NewSpringForMe digital solution Sponsors: Fonds de Dotation HTC Project; Saint-Louis Hospital, Paris, France; Nutricia Nutrition Clinique; Clinicprosport; ELLYE; Association A ïda; Gilead Sciences; Pfizer; Groupe Apicil; Association Laurette Fugain; Fondation du LEEM; Fondation AFNIC; Pierre Fabre Medicament; Novartis Pharmaceuticals; University Hospital, Clermont-Ferrand; LAPSCO, Université Clermont-Auvergne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
Conditions: ST Elevation Myocardial Infarction Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells; Other: Control group Sponsors: Ever Supreme Bio Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Human Induced Pluripotent Stem Cells Derived Natural Killer Cell(XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Conditions: Glioblastoma; GBM Interventions: Biological: XS005 Cell Injection; Drug: Temozolomide （TMZ） Sponsors: Dushu Lake Hospital Affiliated to Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease
Conditions: Regenerative Medicine Interventions: Biological: PRP and PBD-VSEL Stem Cell therapy Sponsors: Fatima Jinnah Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
Conditions: Polycystic Ovary Syndrome (PCOS); Polycystic Ovary Syndrome; PCOS Interventions: Biological: AlloRx Sponsors: The Foundation for Orthopaedics and Regenerative Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors
Conditions: Pain Syndrome; Emotional Stress Interventions: Other: Jing Si Herbal Drink Sponsors: Buddhist Tzu Chi General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Phase IIa Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: exosomes derived from human induced pluripotent stem cell for injection; Drug: a placebo of exosomes derived from human induced pluripotent stem cell for injection Sponsors: Xuanwu Hospital, Beijing; Guidon Pharmaceutics Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
Conditions: Acute Myeloid Leukemia; Leukemia; Leukemia, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Myeloproliferative Disorders Interventions: Biological: Cytokine Induced Memory-like Natural Killer Cells; Biological: Interleukin-2 Sponsors: Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
